au.\*:("O'NEILL GJ")
Results 1 to 25 of 27
Selection :
THE GENETIC CONTROL OF CHIDO AND RODGERS BLOOD GROUP SUBSTANCESO'NEILL GJ.1981; SEMIN. HEMATOL.; ISSN 0037-1963; USA; DA. 1981; VOL. 18; NO 1; PP. 32-38; BIBL. 41 REF.Article
SEROTHERAPY OF A SPONTANEOUS MOUSE TUMOURO'NEILL GJ.1980; BRIT. J. CANCER; GBR; DA. 1980; VOL. 41; NO 5; PP. 839-840; BIBL. 5 REF.Article
CONTROL OF AN EL4 LYMPHOMA IN NUDE MICE BY PASSIVELY ADMINISTERED ANTIBODY.O'NEILL GJ.1976; EUROP. J. CANCER.; G.B.; DA. 1976; VOL. 12; NO 9; PP. 749-751; BIBL. 12 REF.Article
FACTOR B POLYMORPHISM IN NORTH AMERICAN BLACKS: STUDY OF A NEW VARIANT BFF1.35NERL C; O'NEILL GJ.1982; HUMAN GENETICS; ISSN 0340-6717; DEU; DA. 1982; VOL. 61; NO 4; PP. 357-359; BIBL. 19 REF.Article
COMPARATIVE IMMUNOGENICITY OF THY-1.1 AND THY-1.2 ANTIGENS.STAINES NA; O'NEILL GJ.1975; J. IMMUNOGENET.; G.B.; DA. 1975; VOL. 2; NO 4; PP. 223-229; BIBL. 10 REF.Article
LOCOMOTION OF HUMAN LYMPHOID CELLS. I. EFFECT OF CULTURE AND CON A ON T AND NON-T LYMPHOCYTES.O'NEILL GJ; PARROTT DMV.1977; CELL. IMMUNOL.; U.S.A.; DA. 1977; VOL. 33; NO 2; PP. 257-267; BIBL. 14 REF.Article
INFLUENCE OF C. PARVUM ON THE EFFECTIVENESS OF PASSIVE SEROTHERAPY IN THE CONTROL OF THE EL4 LYMPHOMA IN C57BL/6 MICEO'NEILL GJ; STEBBING N.1980; BRIT. J. CANCER; GBR; DA. 1980; VOL. 41; NO 2; PP. 243-249; BIBL. 19 REF.Article
IN VITRO CYTOTOXICITY OF ANTI-THETA (THY-1) ANTIBODIES COMBINED WITH CHLORAMBUCILO'NEILL GJ; PEARSON BA; DAVIES DAL et al.1975; IMMUNOLOGY; G.B.; DA. 1975; VOL. 28; NO 2; PP. 323-329; BIBL. 8REF.Article
TWO HLA-LINKED LOCI CONTROLLING THE FOURTH COMPONENT OF HUMAN COMPLEMENTO'NEILL GJ; SOO YOUNG YANG; DUPONT B et al.1978; PROC. NATION. ACAD. SCI.; USA; DA. 1978; VOL. 75; NO 10; PP. 5165-5169; BIBL. 27 REF.Article
ANALYSIS OF ACTIVE AND INACTIVE COMPLEMENT C4 COMPLOTYPES ASSOCIATED WITH SUBTYPES OF HLA-B17 IN DIFFERENT RACIAL GROUPSO'NEILL GJ; NERL C; POLLACK MS et al.1983; AMERICAN JOURNAL OF HUMAN GENETICS; ISSN 0002-9297; USA; DA. 1983; VOL. 35; NO 2; PP. 309-317; BIBL. 19 REF.Article
SUPPRESSION OF TUMOUR GROWTH IN MICE BY A DRUG-ANTIBODY CONJUGATE USING A NOVEL APPROACH TO LINKAGEROWLAND GF; O'NEILL GJ; DAVIES DAL et al.1975; NATURE; G.B.; DA. 1975; VOL. 255; NO 5508; PP. 487-488; BIBL. 16REF.Article
XENOANTISERA AGAINST LYMPHOID CELLS: SPECIFICITY AND USE IN MONITORING PURIFICATION OF MOUSE AND HUMAN HISTOCOMPATIBILITY ANTIGENS = IMMUNSERUMS XENOGENIQUES CONTRE LES CELLULES LYMPHOIDES: SPECIFICITE ET EMPLOI DANS LE CONTROLE DE LA PURIFICATION D'ANTIGENES D'HISTOCOMPATIBILITE MURINS ET HUMAINSSTAINES NA; O'NEILL GJ; GUY K et al.1973; TISSUE ANTIGENS; DENM.; DA. 1973; VOL. 3; NO 1; PP. 1-21; BIBL. 1P.Serial Issue
ENHANCEMENT OF MACROPHAGE CHEMOTAXIS BY ADJUVANT-ACTIVE BACTERIAWILKINSON PC; O'NEILL GJ; WAPSHAW KG et al.1972; ANN. IMMUNOL.; POLAND; DA. 1972; VOL. 4; NO 3-4; PP. 119-127; BIBL. 1P.1/2Serial Issue
COMPLEMENT C4 ALLOTYPES IN CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY: FURTHER EVIDENCE FOR DIFFERENT ALLELIC VARIANTS AT THE 21-HYDROXYLASE LOCUSO'NEILL GJ; DUPONT B; POLLACK MS et al.1982; CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY; ISSN 0090-1229; USA; DA. 1982; VOL. 23; NO 2; PP. 312-322; BIBL. 39 REF.Article
HETEROGENEITY OF LOCOMOTION IN HUMAN T CELL SUBSETSPARROTT DMV; GOOD RA; O'NEILL GJ et al.1978; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1978; VOL. 75; NO 5; PP. 2392-2395; BIBL. 18 REF.Article
INDUCTION OF HUMAN GRANULOCYTE DIFFERENTIATION IN VITRO BY UBIQUITIN AND THYMOPOIETIN.KAGAN WA; O'NEILL GJ; INCEFY GS et al.1977; BLOOD; U.S.A.; DA. 1977; VOL. 50; NO 2; PP. 275-288; BIBL. 23 REF.Article
ANTIBODY-DRUG SYNERGISM: AN ASSESSMENT OF SPECIFIC PASSIVE IMMUNOTHERAPY IN BRONCHIAL CARCINOMA.NEWMAN CE; FORD CHJ; DAVIES DAL et al.1977; LANCET; G.B.; DA. 1977; NO 8030; PP. 163-166; BIBL. 30 REF.Article
CHIDO AND RODGERS BLOOD GROUPS ARE DISTINCT ANTIGENIC COMPONENTS OF HUMAN COMPLEMENT C4.O'NEILL GJ; SOO YOUNG YANG; TEGOLI J et al.1978; NATURE; G.B.; DA. 1978; VOL. 273; NO 5664; PP. 668-670; BIBL. 18 REF.Article
THE BF LOCUS AND HLA: RARE ALLELES CODING FOR FUNCTIONALLY ACTIVE AND INACTIVE FACTOR-B PRODUCTSO'NEILL GJ; MINITER P; NERL C et al.1982; HUMAN IMMUNOLOGY; ISSN 0198-8859; USA; DA. 1982; VOL. 5; NO 3; PP. 239-246; BIBL. 28 REF.Article
BGB EXPRESSION IN RELATION TO THE HLA-B17 ANTIGEN SPLITS BW57 AND BW58 AND THE CROSS-REACTIONS OF ANTI-BGB ANTIBODIESPOLLACK MS; CRAWFORD MN; ROBINSON HM et al.1982; VOX SANG.; ISSN 0042-9007; CHE; DA. 1982; VOL. 43; NO 1; PP. 1-10; BIBL. 14 REF.Article
C4 POLYMORPHISM AND HLA LINKAGE: STUDIES IN A FAMILY WITH HEREDITARY C4 DEFICIENCYBALLOW M; MCLEAN RH; YUNIS EJ et al.1981; CLIN. IMMUNOL. IMMUNOPATHOL.; ISSN 0090-1229; USA; DA. 1981; VOL. 20; NO 3; PP. 354-360; BIBL. 39 REF.Article
HLA AND COMPLEMENT ALLOTYPES IN TYPE 1 (INSULIN-DEPENDENT) DIABETESMCCLUSKEY J; MCCANN VJ; KAY PH et al.1983; DIABETOLOGIA; ISSN 0012-186X; DEU; DA. 1983; VOL. 24; NO 3; PP. 162-165; BIBL. 22 REF.Article
INHERITED DEFICIENCY OF C8 IN A PATIENT WITH RECURRENT MENINGOCOCCAL INFECTIONS: FURTHER EVIDENCE FOR A DYSFUNCTIONAL C8 MOLECULE AND NONLINKAGE TO THE HLA SYSTEMDENSEN P; BROWN EJ; O'NEILL GJ et al.1983; J. CLIN. IMMUNOL.; ISSN 0271-9142; USA; DA. 1983; VOL. 3; NO 1; PP. 90-99; BIBL. 42 REF.Article
HLA GENOTYPES AND HLA-LINKED GENETIC MARKERS IN ITALIAN PATIENTS WITH CLASSICAL 21-HYDROXYLASE DEFICIENCYPOLLACK MS; NEW MI; O'NEILL GJ et al.1981; HUM. GENET.; ISSN 0340-6717; DEU; DA. 1981; VOL. 58; NO 3; PP. 331-337; BIBL. 27 REF.Article
HLA LINKAGE AND B14, DR1, BFS HAPLOTYPE ASSOCIATION WITH THE GENES FOR LATE ONSET AND CRYPTIC 21-HYDROXYLASE DEFICIENCYPOLLACK MS; LEVINE LS; O'NEILL GJ et al.1981; AM. J. HUM. GENET.; ISSN 0002-9297; USA; DA. 1981; VOL. 33; NO 4; PP. 540-550; BIBL. 30 REF.Article